This is the protocol for a review and there is no abstract. The objectives are as follows:, The primary aim of this review is to investigate the effects of surgically implanted steroids with anti-angiogenic properties in delaying visual loss in exudative macular degeneration. A secondary aim of this review is to compare the clinical outcomes and side effects of different surgically implanted anti-angiogenic steroids. A third aim is to compare the intraocular drug delivery systems used for the administration of steroids in the treatment of exudative AMD in different clinical trials